|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Janeway KA and Grier HE: Sequelae of
osteosarcoma medical therapy: A review of rare acute toxicities and
late effects. Lancet Oncol. 11:670–678. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang J and Zhang W: New molecular insights
into osteosarcoma targeted therapy. Curr Opin Oncol. 25:398–406.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Silverman GA, Bird PI, Carrell RW, Church
FC, Coughlin PB, Gettins PG, Irving JA, Lomas DA, Luke CJ, Moyer
RW, et al: The serpins are an expanding superfamily of structurally
similar but funtionally diverse proteins: Evolution, mechanism of
inhibition, novel functions, and a revised nomenclature. J Biol
Chem. 276:33293–33296. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Valiente M, Obenauf AC, Jin X, Chen Q,
Zhang XH, Lee DJ, Chaft JE, Kris MG, Huse JT, Brogi E and Massagué
J: Serpins promote cancer cell survival and vascular co-option in
brain metastasis. Cell. 156:1002–1016. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Paik PK, Shen R, Won H, Rekhtman N, Wang
L, Sima CS, Arora A, Seshan V, Ladanyi M, Berger MF and Kris MG:
Next-Generation sequencing of stage IV squamous cell lung cancers
reveals an association of PI3K aberrations and evidence of clonal
heterogeneity in patients with brain metastases. Cancer Discov.
5:610–621. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shiiba M, Nomura H, Shinozuka K, Saito K,
Kouzu Y, Kasamatsu A, Sakamoto Y, Murano A, Ono K, Ogawara K, et
al: Down-regulated expression of SERPIN genes located on chromosome
18q21 in oral squamous cell carcinomas. Oncol Rep. 24:241–249.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li Z, Liu Q, Song M, Zheng Y, Nan P, Cao
Y, Chen G, Li Y and Zhong Y: Detecting correlation between sequence
and expression divergences in a comparative analysis of human
serpin genes. Biosystems. 82:226–234. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Erler JT: Cancer: Disabling defences in
the brain. Nature. 508:46–47. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Medress Z and Hayden Gephart M: Molecular
and genetic predictors of breast-to-brain metastasis: Review and
case presentation. Cureus. 7:e2462015.PubMed/NCBI
|
|
11
|
Nagahara A, Nakayama M, Oka D, Tsuchiya M,
Kawashima A, Mukai M, Nakai Y, Takayama H, Nishimura K, Jo Y, et
al: SERPINE2 is a possible candidate promotor for lymph node
metastasis in testicular cancer. Biochem Biophys Res Commun.
391:1641–1646. 2010. View Article : Google Scholar
|
|
12
|
Lee RK, Fan CC, Hwu YM, Lu CH, Lin MH,
Chen YJ and Li SH: SERPINE2, an inhibitor of plasminogen
activators, is highly expressed in the human endometrium during the
secretory phase. Reprod Biol Endocrinol. 9:382011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Demeo DL, Mariani TJ, Lange C, Srisuma S,
Litonjua AA, Celedon JC, Lake SL, Reilly JJ, Chapman HA, Mecham BH,
et al: The SERPINE2 gene is associated with chronic obstructive
pulmonary disease. Am J Hum Genet. 78:253–264. 2006. View Article : Google Scholar :
|
|
14
|
Buchholz M, Biebl A, Neesse A, Wagner M,
Iwamura T, Leder G, Adler G and Gress TM: SERPINE2 (protease nexin
I) promotes extracellular matrix production and local invasion of
pancreatic tumors in vivo. Cancer Res. 63:4945–4951.
2003.PubMed/NCBI
|
|
15
|
Sarrió D, Rodriguez-Pinilla SM, Hardisson
D, Cano A, Moreno-Bueno G and Palacios J: Epithelial-mesenchymal
transition in breast cancer relates to the basal-like phenotype.
Cancer Res. 68:989–997. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bergeron S, Lemieux E, Durand V, Cagnol S,
Carrier JC, Lussier JG, Boucher MJ and Rivard N: The serine
protease inhibitor serpinE2 is a novel target of ERK signaling
involved in human colorectal tumorigenesis. Mol Cancer. 9:2712010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gao S, Krogdahl A, Sørensen JA, Kousted
TM, Dabelsteen E and Andreasen PA: Overexpression of protease
nexin-1 mRNA and protein in oral squamous cell carcinomas. Oral
Oncol. 44:309–313. 2008. View Article : Google Scholar
|
|
18
|
Neesse A, Wagner M, Ellenrieder V, Bachem
M, Gress TM and Buchholz M: Pancreatic stellate cells potentiate
proinvasive effects of SERPINE2 expression in pancreatic cancer
xenograft tumors. Pancreatology. 7:380–385. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Schajowicz F, Sissons HA and Sobin LH: The
World Health Organization's histologic classification of bone
tumors. Cancer. 75:1208–1214. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
21
|
Watanabe R, Iida S, Shimizu Y, Nagata S
and Fukunaga R: SEI family of nuclear factors regulates
p53-dependent transcriptional activation. Genes Cells. 10:851–860.
2005. View Article : Google Scholar
|
|
22
|
Kashkar H, Deggerich A, Seeger JM,
Yazdanpanah B, Wiegmann K, Haubert D, Pongratz C and Krönke M:
NF-kappaB-independent down-regulation of XIAP by bortezomib
sensitizes HL B cells against cytotoxic drugs. Blood.
109:3982–3988. 2007. View Article : Google Scholar
|
|
23
|
Wang K, Wang B, Xing AY, Xu KS, Li GX and
Yu ZH: Prognostic significance of SERPINE2 in gastric cancer and
its biological function in SGC7901 cells. J Cancer Res Clin Oncol.
141:805–812. 2015. View Article : Google Scholar
|
|
24
|
Hannemann J, Oosterkamp HM, Bosch CA,
Velds A, Wessels LF, Loo C, Rutgers EJ, Rodenhuis S and van de
Vijver MJ: Changes in gene expression associated with response to
neoadjuvant chemotherapy in breast cancer. J Clin Oncol.
23:3331–3342. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
van't Veer LJ, Dai H, Van de Vijver MJ, He
YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ,
Witteveen AT, et al: Gene expression profiling predicts clinical
outcome of breast cancer. Nature. 415:530–536. 2002. View Article : Google Scholar
|
|
26
|
Holleman A, Cheok MH, den Boer ML, Yang W,
Veerman AJ, Kazemier KM, Pei D, Cheng C, Pui CH, Relling MV, et al:
Gene-expression patterns in drug-resistant acute lymphoblastic
leukemia cells and response to treatment. N Engl J Med.
351:533–542. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Vaillant C, Valdivieso P, Nuciforo S, Kool
M, Schwarzentruber-Schauerte A, Méreau H, Cabuy E, Lobrinus JA,
Pfister S, Zuniga A, et al: Serpine2/PN-1 is required for
proliferative expansion of pre-neoplastic lesions and malignant
progression to medulloblastoma. PLoS One. 10:e01248702015.
View Article : Google Scholar : PubMed/NCBI
|
